Template:Bleeding: Difference between revisions

Jump to navigation Jump to search
Gerald Chi (talk | contribs)
mNo edit summary
GeraldChi (talk | contribs)
No edit summary
 
(21 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{| class="infobox bordered" style="width: 15%; text-align: left; font-size: 90%; background:AliceBlue"
{| class="infobox bordered" style="width: 18%; text-align: left; font-size: 85%; background:AliceBlue"
|-
|-
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |
Line 7: Line 7:
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"
!
!
|- bgcolor="LightCoral"
|- bgcolor="LightCoral"
!
!
Line 13: Line 12:
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
Line 19: Line 17:
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
Line 25: Line 22:
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
Line 31: Line 27:
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
Bleeding Definitions From Cardiovascular Trials
: [[Bleeding Academic Research Consortium]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[Bleeding background|Background]]
: [[TIMI bleeding criteria]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[TIMI bleeding criteria]]
: [[GUSTO bleeding criteria]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[GUSTO]]
: [[CURE bleeding criteria]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[CURE]]
: [[ACUITY HORIZONS bleeding criteria]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[ACUITY HORIZONS]]
: [[STEEPLE bleeding criteria]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[STEEPLE]]
: [[PLATO bleeding criteria]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
:[[PLATO]]
: [[GRACE bleeding criteria]]
|-  
|-  
!
!
|- bgcolor="Pink"
!
:[[GRACE bleeding criteria]]
|-
!
|- bgcolor="Pink"
!
:[[Bleeding Academic Research Consortium]]
|-
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
Line 97: Line 72:
|-  
|-  
!
!
|- bgcolor="CadetBlue"
|- bgcolor="CadetBlue"
!
!
Line 103: Line 77:
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
Line 109: Line 82:
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
Postoperative Bleeding
[[Bleeding reversal of anticoagulation and antiplatelet in active bleed|Reversal of Anticoagulation and Antiplatelet in Active Bleed]]
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
: [[Postoperative bleeding coagulation monitoring|Coagulation Monitoring]]
Perioperative Bleeding
 
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
: [[Postoperative bleeding anemia management|Anemia Management]]
: [[Bleeding perioperative bleeding anemia management|Anemia Management]]
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
: [[Postoperative bleeding coagulation management|Coagulation Management]]
: [[Bleeding perioperative bleeding monitoring of coagulation status and platelet function|Coagulation Monitoring]]
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
: [[Postoperative bleeding multimodal approach in specific clinical fields|Specific Clinical Fields]]
: [[Bleeding perioperative bleeding coagulation management|Coagulation Management]]
|-  
|-
!
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
: [[Postoperative bleeding anticoagulation and antiplatelet therapy|Anticoagulation and Antiplatelet Therapy]]
: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy|Discontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy]]
|-  
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Antiplatelet Agents|Antiplatelet Agents]]
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Heparin|Heparin]]
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Fondaparinux|Fondaparinux]]
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Vitamin K Antagonists|Vitamin K Antagonists]]
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#New Oral Anticoagulants|New Oral Anticoagulants]]
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Comorbidities Involving Hemostatic Derangement|Comorbidities Involving Hemostatic Derangement]]
|-
!
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
: [[Postoperative bleeding comorbidities with hemostatic derangements and congenital bleeding disorders |Comorbidities with Hemostatic Derangements and Congenital Bleeding Disorders]]
: [[Bleeding perioperative bleeding management in specific surgeries|Specific Surgeries]]
:: [[Bleeding perioperative bleeding management in specific surgeries#Cardiovascular Surgery|Cardiovascular Surgery]]
:: [[Bleeding perioperative bleeding management in specific surgeries#Gynecological (Non-Pregnant) Bleeding|Gynecological Bleeding]]
:: [[Bleeding perioperative bleeding management in specific surgeries#Obstetric Bleeding|Obstetric Bleeding]]
:: [[Bleeding perioperative bleeding management in specific surgeries#Orthopedic Surgery and Neurosurgery|Orthopedic/Neurosurgery]]
:: [[Bleeding perioperative bleeding management in specific surgeries#Visceral and Transplant Surgery|Visceral/Transplant Surgery]]
:: [[Bleeding perioperative bleeding management in specific surgeries#Pediatric Surgery|Pediatric Surgery]]
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Bleeding miscellaneous|Miscellaneous]]
: [[Bleeding perioperative bleeding prevention and treatment in patients with congenital bleeding disorders|Congenital Bleeding Disorders]]
 
:: [[Bleeding perioperative bleeding prevention and treatment in patients with congenital bleeding disorders#von Willebrand Disease|von Willebrand Disease]]
:: [[Bleeding perioperative bleeding prevention and treatment in patients with congenital bleeding disorders#Platelet Defects|Platelet Defects]]
:: [[Bleeding perioperative bleeding prevention and treatment in patients with congenital bleeding disorders#Hemophilia A and B|Hemophilia A and B]]
:: [[Bleeding perioperative bleeding prevention and treatment in patients with congenital bleeding disorders#Factor VII Deficiency|Factor VII Deficiency]]
:: [[Bleeding perioperative bleeding prevention and treatment in patients with congenital bleeding disorders#Rare Bleeding Disorders|Rare Bleeding Disorders]]
|-  
|-  
!
!
|- bgcolor="PaleGoldenrod "
|- bgcolor="PaleGoldenrod "
!
!
Line 165: Line 144:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 171: Line 149:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 177: Line 154:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 183: Line 159:
|-  
|-  
!
!
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 189: Line 164:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 195: Line 169:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 201: Line 174:
|-  
|-  
!
!
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 212: Line 184:
|-  
|-  
!
!
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 218: Line 189:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 224: Line 194:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 230: Line 199:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 236: Line 204:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 242: Line 209:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 248: Line 214:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 254: Line 219:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 260: Line 224:
|-  
|-  
!  
!  
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
Line 266: Line 229:
|-  
|-  
!  
!  
|}
|}

Latest revision as of 13:10, 25 April 2014